Morphine Sulfate | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Morphine Sulfate
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Morphine Sulfate

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Morphine Sulfate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 12 USDMF, 6 CEP/COS, 4 KDMF, 14 NDC API, 11 Listed Suppliers, $ API Reference Price

33 API Suppliers
12 USDMF
6 CEP/COS
4 KDMF
14 NDC API
11 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

51 Drugs in Development

51 Drugs in Development

FINISHED DOSAGE FORMULATIONS

636 FDF Dossiers, 223 FDA Orange Book, 169 Europe, 49 Canada, 109 Australia, 22 South Africa, 64 Listed Dossiers

636 FDF Dossiers
223 FDA Orange Book
169 Europe
49 Canada
109 Australia
22 South Africa
64 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 100MG, TABLET, EXTENDED RELEASE;ORAL - 15MG, TABLET, EXTENDED RELEASE;ORAL - 200MG, TABLET, EXTENDED RELEASE;ORAL - 30MG, TABLET, EXTENDED RELEASE;ORAL - 60MG, INJECTABLE;INJECTION - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAMUSCULAR - 10MG/0.7ML (10MG/0.7ML), INJECTABLE;INJECTION - 10MG/ML, INJECTABLE;INJECTION - 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2MG/ML, INJECTABLE;INJECTION - 4MG/ML, INJECTABLE;INJECTION - 50MG/ML, INJECTABLE;INJECTION - 8MG/ML, CAPSULE, EXTENDED RELEASE;ORAL - 100MG, CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 130MG, CAPSULE, EXTENDED RELEASE;ORAL - 150MG, CAPSULE, EXTENDED RELEASE;ORAL - 200MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, CAPSULE, EXTENDED RELEASE;ORAL - 70MG, CAPSULE, EXTENDED RELEASE;ORAL - 80MG, TABLET, EXTENDED RELEASE;ORAL - 100MG, TABLET, EXTENDED RELEASE;ORAL - 15MG, TABLET, EXTENDED RELEASE;ORAL - 30MG, TABLET, EXTENDED RELEASE;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 15MG, TABLET, EXTENDED RELEASE;ORAL - 30MG, TABLET, EXTENDED RELEASE;ORAL - 60MG, SOLUTION;ORAL - 100MG/5ML, SOLUTION;ORAL - 10MG/5ML, SOLUTION;ORAL - 20MG/5ML, TABLET;ORAL - 15MG, TABLET;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 100MG
TABLET, EXTENDED RELEASE;ORAL - 15MG
TABLET, EXTENDED RELEASE;ORAL - 200MG
TABLET, EXTENDED RELEASE;ORAL - 30MG
TABLET, EXTENDED RELEASE;ORAL - 60MG
INJECTABLE;INJECTION - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAMUSCULAR - 10MG/0.7ML (10MG/0.7ML)
INJECTABLE;INJECTION - 10MG/ML
INJECTABLE;INJECTION - 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 2MG/ML
INJECTABLE;INJECTION - 4MG/ML
INJECTABLE;INJECTION - 50MG/ML
INJECTABLE;INJECTION - 8MG/ML
CAPSULE, EXTENDED RELEASE;ORAL - 100MG
CAPSULE, EXTENDED RELEASE;ORAL - 10MG
CAPSULE, EXTENDED RELEASE;ORAL - 130MG
CAPSULE, EXTENDED RELEASE;ORAL - 150MG
CAPSULE, EXTENDED RELEASE;ORAL - 200MG
CAPSULE, EXTENDED RELEASE;ORAL - 20MG
CAPSULE, EXTENDED RELEASE;ORAL - 30MG
CAPSULE, EXTENDED RELEASE;ORAL - 40MG
CAPSULE, EXTENDED RELEASE;ORAL - 50MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
CAPSULE, EXTENDED RELEASE;ORAL - 70MG
CAPSULE, EXTENDED RELEASE;ORAL - 80MG
TABLET, EXTENDED RELEASE;ORAL - 100MG
TABLET, EXTENDED RELEASE;ORAL - 15MG
TABLET, EXTENDED RELEASE;ORAL - 30MG
TABLET, EXTENDED RELEASE;ORAL - 60MG
TABLET, EXTENDED RELEASE;ORAL - 15MG
TABLET, EXTENDED RELEASE;ORAL - 30MG
TABLET, EXTENDED RELEASE;ORAL - 60MG
SOLUTION;ORAL - 100MG/5ML
SOLUTION;ORAL - 10MG/5ML
SOLUTION;ORAL - 20MG/5ML
TABLET;ORAL - 15MG
TABLET;ORAL - 30MG
CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 12 Evonik, 4 Rochem International Inc, 18 SPI Pharma, 23 DKSH, 2 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 13 Kirsch Pharma, 4 ACG Worldwide, 15 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 36 BASF, 1 Bioplus Life Sciences, 4 CD Formulation, 2 Clariant, 17 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 4 Finar, 12 Gangwal Chemicals, 14 Ideal Cures, 3 Ingredion Pharma Solutions, 26 Kerry, 1 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 9 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 27 Roquette, 15 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

91 Fillers, Diluents & Binders, 79 Coating Systems & Additives, 54 Controlled & Modified Release, 48 Thickeners and Stabilizers, 43 Parenteral, 39 Solubilizers, 39 Topical, 38 Direct Compression, 32 Granulation, 30 Taste Masking, 27 Film Formers & Plasticizers, 21 Lubricants & Glidants, 19 Chewable & Orodispersible Aids, 15 Co-Processed Excipients, 15 Disintegrants & Superdisintegrants, 13 Rheology Modifiers, 12 Emulsifying Agents, 9 Empty Capsules, 8 API Stability Enhancers, 7 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

91 Fillers, Diluents & Binders
79 Coating Systems & Additives
54 Controlled & Modified Release
48 Thickeners and Stabilizers
43 Parenteral
39 Solubilizers
39 Topical
38 Direct Compression
32 Granulation
30 Taste Masking
27 Film Formers & Plasticizers
21 Lubricants & Glidants
19 Chewable & Orodispersible Aids
15 Co-Processed Excipients
15 Disintegrants & Superdisintegrants
13 Rheology Modifiers
12 Emulsifying Agents
9 Empty Capsules
8 API Stability Enhancers
7 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 121 News #PharmaBuzz

1 Data Compilation #PharmaFlow
121 News #PharmaBuzz

GLOBAL SALES INFORMATION

26 US Medicaid Prescriptions, 186 Regulatory FDF Prices

26 US Medicaid Prescriptions
186 Regulatory FDF Prices

MARKET PLACE

19 APIs, 19 FDF Dossiers

19 APIs
19 FDF Dossiers

PATENTS & EXCLUSIVITIES

88 US Patents, 23 Health Canada Patents

88 US Patents
23 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 11 Others

2 EDQM
11 Others

$ API Ref.Price (USD/KG) : 17,035 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

49 All

01 6ETHYPHARM INC

02 4BGP PHARMA ULC

03 2ENDO OPERATIONS LTD.

04 2FRESENIUS KABI CANADA LTD

05 3JAMP PHARMA CORPORATION

06 2PHARMASCIENCE INC

07 9PURDUE PHARMA

08 12SANDOZ CANADA INCORPORATED

09 3STERIMAX INC

10 1STERINOVA INC.

11 5TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

49 All

01 49MORPHINE SULFATE

filter Dosage Form Reset all filters

49 All

01 6CAPSULE (EXTENDED RELEASE)

02 4CAPSULE (SUSTAINED-RELEASE)

03 3LIQUID

04 13SOLUTION

05 4TABLET

06 15TABLET (EXTENDED-RELEASE)

07 4TABLET (IMMEDIATE RELEASE)

filter Brand Name Reset all filters

49 All

01 4KADIAN

02 6M-ESLON

03 1MORPHINE HP 50

04 2MORPHINE LP EPIDURAL

05 1MORPHINE SULFATE INJ 10MG/ML USP

06 1MORPHINE SULFATE INJ 15MG/ML USP

07 3MORPHINE SULFATE INJECTION

08 1MORPHINE SULFATE INJECTION BP

09 2MORPHINE SULFATE INJECTION EPIDURAL

10 1MORPHINE SULFATE INJECTION SDZ

11 2MORPHINE SULFATE INJECTION USP

12 2MORPHINE SULFATE INJECTION, USP

13 5MS CONTIN

14 4MS.IR

15 2PMS-MORPHINE SULFATE

16 5SANDOZ MORPHINE SR

17 2STATEX

18 5TEVA-MORPHINE SR

Veranova Morphine Sulfate

List of Suppliers

Product Main Page

01

ETHYPHARM INC

CPhI WW Frankfurt

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Canada

MORPHINE SULFATE

Brand Name : M-ESLON

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 30MG

Packaging : 20/50

Approval Date :

Application Number : 2019949

Regulatory Info :

Registration Country : Canada

Product Web Link

Digital Content

02

ETHYPHARM INC

CPhI WW Frankfurt

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Canada

MORPHINE SULFATE

Brand Name : M-ESLON

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 100MG

Packaging : 20/50

Approval Date :

Application Number : 2019965

Regulatory Info :

Registration Country : Canada

Product Web Link

Digital Content

03

ETHYPHARM INC

CPhI WW Frankfurt

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Canada

MORPHINE SULFATE

Brand Name : M-ESLON

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 60MG

Packaging : 20/50

Approval Date :

Application Number : 2019957

Regulatory Info :

Registration Country : Canada

Product Web Link

Digital Content

04

ETHYPHARM INC

CPhI WW Frankfurt

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Canada

MORPHINE SULFATE

Brand Name : M-ESLON

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 10MG

Packaging : 20/50

Approval Date :

Application Number : 2019930

Regulatory Info :

Registration Country : Canada

Product Web Link

Digital Content

05

ETHYPHARM INC

CPhI WW Frankfurt

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Canada

MORPHINE SULFATE

Brand Name : M-ESLON

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 200MG

Packaging : 20/50

Approval Date :

Application Number : 2177757

Regulatory Info :

Registration Country : Canada

Product Web Link

Digital Content

06

ETHYPHARM INC

CPhI WW Frankfurt

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Canada

MORPHINE SULFATE

Brand Name : M-ESLON

Dosage Form : CAPSULE (EXTENDED RELEASE)

Dosage Strength : 15MG

Packaging : 20/50

Approval Date :

Application Number : 2177749

Regulatory Info :

Registration Country : Canada

Product Web Link

Digital Content

07

SANDOZ CANADA INCORPORATED

CPHI Shenzhen

Not Confirmed

SANDOZ CANADA INCORPORATED

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

MORPHINE SULFATE

Brand Name : MORPHINE SULFATE INJ 15MG/ML USP

Dosage Form : LIQUID

Dosage Strength : 15MG/ML

Packaging : 10X1ML/25X1ML/1X30ML

Approval Date :

Application Number : 392561

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

SANDOZ CANADA INCORPORATED

CPHI Shenzhen

Not Confirmed

SANDOZ CANADA INCORPORATED

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

MORPHINE SULFATE

Brand Name : MORPHINE SULFATE INJ 10MG/ML USP

Dosage Form : LIQUID

Dosage Strength : 10MG/ML

Packaging : 10X1ML/25X1ML

Approval Date :

Application Number : 392588

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

ENDO OPERATIONS LTD.

Country

CPHI Shenzhen

Not Confirmed

ENDO OPERATIONS LTD.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : Canada

MORPHINE SULFATE

Brand Name : STATEX

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100

Approval Date :

Application Number : 594644

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

ENDO OPERATIONS LTD.

Country

CPHI Shenzhen

Not Confirmed

ENDO OPERATIONS LTD.

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : Canada

MORPHINE SULFATE

Brand Name : STATEX

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100

Approval Date :

Application Number : 594652

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!